Drug-resistant tuberculosis medical therapy: Difference between revisions
No edit summary |
|||
| Line 10: | Line 10: | ||
*Medical treatment for MDR-TB consists of at least 4 drugs that have shown effectiveness against MDR. | *Medical treatment for MDR-TB consists of at least 4 drugs that have shown effectiveness against MDR. | ||
*Treatment duration will depend on the culture results. The duration of therapy should be > 18 months after culture is negative. | *Treatment duration will depend on the culture results. The duration of therapy should be > 18 months after culture is negative. | ||
*Chronic cases with severe pulmonary disease may require more than 24 months of therapy. | |||
{| | {| | ||
| valign=top | | | valign=top | | ||
| Line 57: | Line 58: | ||
▸ '''Para-aminosalicylic acid'''<br> OR <br> ▸ '''Cycloserine'''<br> OR <br> ▸ '''Terizidone'''<br> OR <br> ▸ '''Ethionamide'''<br> OR <br> ▸ '''Protionamide''' | ▸ '''Para-aminosalicylic acid'''<br> OR <br> ▸ '''Cycloserine'''<br> OR <br> ▸ '''Terizidone'''<br> OR <br> ▸ '''Ethionamide'''<br> OR <br> ▸ '''Protionamide''' | ||
|- | |- | ||
| style="font-size: 90%; padding: 0 5px; background: #DCDCDC;" align=left |<small>Table adapted from WHO 2013 Treatment of tuberculosis: guidelines – 4th ed.<ref name="WHO 2013"> {{Citeweb | url= http://www.who.int/tb/publications/tb_treatmentguidelines/en/| Title= 2013 WHO Treatment of Tuberculosis: Guidelines for National Programmes}}</ref></small> | |||
|} | |} | ||
|} | |} | ||
Revision as of 15:36, 17 September 2014
|
Tuberculosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Drug-resistant tuberculosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Drug-resistant tuberculosis medical therapy |
|
Risk calculators and risk factors for Drug-resistant tuberculosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alejandro Lemor, M.D. [2]
Overview
Multiple Drug-Resistant (MDR) Tuberculosis
- MDR-TB is defined as resistance to isoniazid and rifampicin, with or without resistance to other first-line drugs.
- Medical treatment for MDR-TB consists of at least 4 drugs that have shown effectiveness against MDR.
- Treatment duration will depend on the culture results. The duration of therapy should be > 18 months after culture is negative.
- Chronic cases with severe pulmonary disease may require more than 24 months of therapy.
|
MDR Tuberculosis ▸ Adults ▸ Children |
|
Extensively Drug-Resistant XDR Tuberculosis
XDR-TB is defined as resistance to at least isoniazid and rifampicin, and to any fluoroquinolone, and to any of the three second-line injectables (amikacin, capreomycin, and kanamycin).
|
XDR Tuberculosis ▸ Adults ▸ Children |
|